Trial By Error: Another CBT/GET Marketing Document Masquerading as Research from Professor Chalder
virology blog,
By David Tuller, DrPH It’s another month, and here’s another worthless paper from Trudie Chalder, King’s College London’s…
By David Tuller, DrPH It’s another month, and here’s another worthless paper from Trudie Chalder, King’s College London’s…
by David Tuller…
From PLOSone, 2 May 2017. Expression of Concern: Adaptive Pacing, Cognitive Behaviour Therapy, Graded Exercise, and Specialist…
0000-0003-1258-0746The considerations about open data and making data more accessible and reusable have increasingly come to…
Do not think it worth while to proceed by concealing evidence, for the evidence is sure to come to light. -Bertrand…
By David Tuller…
The world’s highest impact factor medical journal, the New England Journal of Medicine (NEJM), seems to have been doing some…
I was without Internet until my plane from Zurich touched down in Philadelphia. Gmail wasn’t loading as we taxied in on the…
A tribunal in the UK has rejected an appeal by Queen Mary University of London, who sought to reverse a previous order that…
Host: Vincent Racaniello Guest: David Tuller Vincent speaks with David Tuller about flaws in the U.K's $8 million PACE trial…
PLoS…
Researchers have removed the previously openly available anonymised patient data of the clinical trial FINE from their…
The Lancet, an elite medical journal published by Elsevier, is responsible for a number of controversial publications, on which…
Amy Mollett, Social Media Manager, rounds up how LSE currently uses Twitter for sharing research, interacting with…
Amy Mollett, Social Media Manager at the London School of Economics, rounds up how LSE currently uses Twitter for sharing…
A prominent notice has appeared on the PLOS One…
The title is my interpretation of the implications of some announcements now appearing in British media. There are more…
Repeated signals that The BMJ is moving forward while editors of other key medical journals try to undermine data sharing.
We are at a tipping point in the struggle for routine data-sharing. We look to journals to implement policies based on a…
Data sharing is all over academic news now. We had Research Parasites, a noxious species of scientists who want to analyse…
In recent months, two developments have provided some degree of optimism to people with the illness variously called chronic…
Hey, PROSPERO, we’ve got a problem. Vincent Price as Prince…
On October 23rd, virology blog published the third installment of David Tuller’s investigative report about the PACE study of…
In bringing up “protecting patient privacy” in refusing to release the PACE trial data published in PLOS One, King’s College…
“We stand by our decisions to decline two recent applications for trial data as we believe that they did not meet these…
Several times when I was the editor of The BMJ the journal was declared the worst medical journal in the world by the ME (Myalgic…
After a request for the original data was denied, PLOS ONE editors have flagged a 2012 sub analysis of a controversial clinical…
The simple answer is that I am not involved in the decision-making process and it is a bit opaque to me. The more elaborate…
Kudos to Dutch research biologist Klaas van Dijk. for his letter to PLOS One: Dear Editors of PLOS One, Attached is a formal…
By David Tuller…
Professors Peter White, Trudie Chalder and Michael Sharpe (co-principal investigators of the PACE trial) respond to the three…
By David Tuller…
From the ‘Virology Blog‘, 21 October 2015. Words by the American freelance writer and academic, David Tuller. David Tuller is…
By David Tuller…